[go: up one dir, main page]

JPH03191864A - Indirect agglutination immunoassay method and device - Google Patents

Indirect agglutination immunoassay method and device

Info

Publication number
JPH03191864A
JPH03191864A JP1329556A JP32955689A JPH03191864A JP H03191864 A JPH03191864 A JP H03191864A JP 1329556 A JP1329556 A JP 1329556A JP 32955689 A JP32955689 A JP 32955689A JP H03191864 A JPH03191864 A JP H03191864A
Authority
JP
Japan
Prior art keywords
particles
magnetic
container
immunoassay
forcibly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1329556A
Other languages
Japanese (ja)
Other versions
JP2683944B2 (en
Inventor
Tomoo Saito
斉藤 智雄
Mikio Ikeda
池田 幹雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP1329556A priority Critical patent/JP2683944B2/en
Priority to CA002028995A priority patent/CA2028995A1/en
Priority to DE69007587T priority patent/DE69007587T2/en
Priority to ES90120939T priority patent/ES2054195T3/en
Priority to EP90120939A priority patent/EP0426170B1/en
Priority to KR1019900017534A priority patent/KR940009958B1/en
Priority to AU65720/90A priority patent/AU626044B2/en
Publication of JPH03191864A publication Critical patent/JPH03191864A/en
Priority to US08/082,373 priority patent/US6258607B1/en
Application granted granted Critical
Publication of JP2683944B2 publication Critical patent/JP2683944B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To make it possible to automate the entire process of indirect agglutination simply by using magnetic particles or particles containing magnetic material as a carrier, and forcibly settling the carrier to the bottom part of a container by using magnetic force. CONSTITUTION:Magnetic particles or particles containing magnetic material are used as reagent, and an immunity measuring system comprising indirect agglutination is constituted. After the reaction, the component containing the particles is forcibly settled to the bottom of a container with magnetic force. Then, the container is inclined, and the presence or absence of the immunity reaction is judged based on the releasing state of the settled particles from the container. When the component containing the magnetic particles or the particles containing the magnetic material are forcibly settled with the magnetic force, an electromagnet or a permanent magnet can be used. The magnetic particles are forcibly settled on a settling accelerating stage using the magnet and attracted to the bottom surface of the container. The same action as the settlement using a centrifugal method can be obtained. Thus, the measurement can be carried out in a short time with no influence of variation or the like.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は磁性体粒子又は磁性体を含む粒子を用い、抗原
抗体反応を利用した間接凝集免疫測定方法及び装置に関
するものである。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to an indirect agglutination immunoassay method and apparatus that utilizes antigen-antibody reactions using magnetic particles or particles containing magnetic substances.

(従来の技術) 免疫測定方法の一つとして、抗原抗体反応によって起る
結合反応を抗原又は抗体を結合させた粒子を用いて感度
を高めて測定する間接凝集反応は、受身凝集反応又は逆
受身凝集反応と呼ばれ多量検体の簡易測定法として広く
実用化されている。
(Prior art) As one of the immunoassay methods, the indirect agglutination reaction is a passive agglutination reaction or a reverse passive agglutination reaction in which the binding reaction caused by the antigen-antibody reaction is measured using particles to which antigens or antibodies are bound to increase the sensitivity. This reaction is called agglutination reaction and is widely used as a simple method for measuring large amounts of samples.

(本発明が解決しようとする問題点) 間接凝集反応による免疫測定法は、EIA(酵素免疫測
定法)やRIA(放射免疫測定法)等に比べ操作が簡便
であり、最終の抗原抗体反応の有無の判定にも特別な機
器を要しない等の特徴がある。
(Problems to be solved by the present invention) Immunoassay using indirect agglutination reaction is easier to operate than EIA (enzyme immunoassay), RIA (radioimmunoassay), etc. It has features such as not requiring any special equipment to determine the presence or absence.

しかしながら、その操作に熟練を要する、あるいは自動
化が困難である等の欠点があり、今もって部分自動化の
域を出ない状態である。
However, there are drawbacks such as the need for skill to operate it and the difficulty of automation, and it is still in a state where it can only be partially automated.

また間接凝集法のパターン形成法としては、U字型又は
V字型のマイクロプレートに所定の希釈検体溶液に所定
の試薬粒子液を添加、撹拌後静置し、粒子の沈降パター
ンから抗原抗体反応の有無を判断する方法(以下静置法
と省略する)と、■字型のマイクロプレートの底に粒子
を遠心力を用いて強制的に沈降させ、その後マイクロプ
レートを傾斜させた状態に置き、粒子の底からの剥離状
況から抗原抗体反応の有無を判断する方法(以下遠心法
と省略する)とがある。前者の静置法による沈降パター
ンから抗原抗体反応の有無を判断する場合には、静置中
の振動によるパターンの乱れ、例えばスリップ現象の誘
発、パターン面積の減少等が起こりやすく自動化を困難
にしていた。更に静置法のもう一つの欠点は、パターン
形成の完成までに、使用する粒子によっても異なるが、
約0゜5乃至3時間もの長時間を要することである。又
後者の遠心法では、遠心機を用いて沈降を数分で行ない
、その後マイクロプレートを傾斜させ数分でパターン読
取りが行なえ、パターン形成中、振動が加わることによ
るパターンの乱れを心配する必要がない等の利点がある
が、実際上、遠心機を用いて自動的に免疫測定を行なう
ことは技術的に困難である。
In addition, as a pattern forming method for indirect agglutination, a predetermined reagent particle solution is added to a predetermined diluted sample solution in a U-shaped or V-shaped microplate, stirred and left to stand, and the antigen-antibody reaction is detected from the sedimentation pattern of the particles. The method for determining the presence or absence of particles (hereinafter abbreviated as the standing method) involves forcibly settling particles at the bottom of a ■-shaped microplate using centrifugal force, and then placing the microplate in an inclined state. There is a method (hereinafter abbreviated as centrifugation method) in which the presence or absence of an antigen-antibody reaction is determined based on the state of separation of particles from the bottom. When determining the presence or absence of an antigen-antibody reaction from the sedimentation pattern obtained by the former standing method, the pattern is likely to be disturbed due to vibration during the standing, such as inducing a slip phenomenon and reducing the pattern area, making automation difficult. Ta. Another disadvantage of the static method is that the amount of time required to complete pattern formation varies depending on the particles used.
It takes a long time of about 0.5 to 3 hours. In addition, with the latter centrifugation method, sedimentation is performed in a few minutes using a centrifuge, and then the microplate is tilted and the pattern can be read in a few minutes, and there is no need to worry about pattern disturbance due to vibrations during pattern formation. However, in practice, it is technically difficult to automatically perform immunoassay using a centrifuge.

また、前記した従来の静置法及び遠心法とも測定に用い
る検体としては、例えば血清、尿、その他体液等を挙げ
ることができる。従来の方法では、検体は希釈して使用
するものの、血球と血清の分離操作を省き全血液(以下
全血と省略する)を使用すると底面の一点に集中して沈
降パターンを形成するため血液成分が凝集像に大きな影
響を及ぼし間違った判定結果を与えることが知られてい
る。
In addition, examples of specimens used for measurement in both the above-mentioned conventional static method and centrifugation method include serum, urine, and other body fluids. In conventional methods, the sample is diluted before use, but when whole blood (hereinafter referred to as whole blood) is used without the separation of blood cells and serum, blood components concentrate at one point on the bottom and form a sedimentation pattern. is known to have a large effect on the agglutination image and give incorrect judgment results.

そのため血球と血清との分離する前処理操作が必須のも
のとなっている。
Therefore, a pretreatment operation for separating blood cells and serum is essential.

さらに、他の免疫測定法例えば、酵素免疫測定法、放射
免疫測定法等においても、血球と血清の分離操作は、非
特異反応を回避するため前処理操作として用いられてい
るのが現状である。
Furthermore, in other immunoassay methods such as enzyme immunoassay and radioimmunoassay, the separation of blood cells and serum is currently used as a pretreatment procedure to avoid non-specific reactions. .

(問題点を解決するための手段) 本発明の目的は、従来の上記の欠点を回避し、簡便なさ
らには間接凝集反応の全過程を自動化した磁気沈降促進
型の間接凝集免疫測定方法及び装置を提供することであ
る。
(Means for Solving the Problems) An object of the present invention is to avoid the above-mentioned drawbacks of the conventional methods, and to provide a method and apparatus for indirect agglutination immunoassay using magnetic precipitation promotion, which is simple and automates the entire process of indirect agglutination reaction. The goal is to provide the following.

本発明の磁気沈降促進型の間接凝集免疫測定方法(以下
「凝集免疫測定方法Jという)は、試薬として磁性体粒
子又は磁性体を含む粒子を用いて間接凝集反応による免
疫測定系を構成し、反応後該粒子を含む成分を容器底部
に磁力により強制沈降させ、次に該容器を傾斜させ、沈
降粒子の該容器からの剥離状況から免疫反応の有無を判
断する凝集免疫測定方法である。本発明の凝集免疫測定
方法において、磁性体粒子又は磁性体を含む粒子を含む
成分を磁力により強制沈降させるには、電磁石を用いて
も永久磁石を用いてもよい。
The magnetic precipitation-promoted indirect agglutination immunoassay method (hereinafter referred to as "Agglutination immunoassay method J") of the present invention comprises an immunoassay system based on an indirect agglutination reaction using magnetic particles or particles containing a magnetic substance as a reagent, This is an agglutination immunoassay method in which the component containing the particles is forcibly settled at the bottom of the container after the reaction by magnetic force, the container is then tilted, and the presence or absence of an immune reaction is determined from the detachment of the precipitated particles from the container. In the agglutination immunoassay method of the invention, an electromagnet or a permanent magnet may be used to forcibly settle magnetic particles or a component containing particles containing a magnetic substance by magnetic force.

本発明の間接凝集免疫測定装置は免疫測定用検体及び免
疫測定用試薬を受容する該免疫測定用試薬の磁性体又は
磁性体を含む粒子を含む成分の沈降を磁力によって強制
沈降させる手段と、該容器を傾斜させた状態に置く手段
とを有するものである。即ち、本発明においては、磁石
を用いた沈降促進台上で磁性体粒子を強制的に沈降させ
、容器底面に引き寄せ、あたかも遠心法で沈降させたの
と同じ作用を得ることができる。これにより従来の静置
法で要した時間の三分の一以下の短時間で、しかも振動
等に影響を受けない測定方法と装置を完成することがで
きる。
The indirect agglutination immunoassay device of the present invention includes a means for receiving an immunoassay sample and an immunoassay reagent, and forcibly sedimenting a component containing a magnetic substance or particles containing a magnetic substance in the immunoassay reagent using a magnetic force; and means for placing the container in an inclined position. That is, in the present invention, the magnetic particles are forcibly settled on a sedimentation promotion table using a magnet, and are attracted to the bottom of the container, thereby achieving the same effect as if they were sedimented using a centrifugal method. This makes it possible to complete a measuring method and device that takes less than one-third of the time required by the conventional standing method and is not affected by vibrations or the like.

本発明において試薬中に含まれる磁性体としては、底面
に強制的に沈降させるために磁性体の中でも強磁性体を
好適に使用することができる。また本発明において試薬
として使用できる磁性体粒子又は磁性体を含む粒子の具
体例は以下の通りである。
In the present invention, as the magnetic substance contained in the reagent, a ferromagnetic substance can be suitably used among magnetic substances in order to force the reagent to settle on the bottom surface. Further, specific examples of magnetic particles or particles containing a magnetic substance that can be used as a reagent in the present invention are as follows.

磁性体粒子、強磁性体を含んだゼラチン粒子(特開昭5
9−195161号参照)、磁性体を血清アルブミン等
で被覆した粒子、同様に合成ポリマーで被覆した粒子、
合成ポリマー中磁性体を含んだ粒子等である。
Magnetic particles, gelatin particles containing ferromagnetic material (Unexamined Japanese Patent Publication No. 5
9-195161), particles coated with a magnetic material such as serum albumin, particles similarly coated with a synthetic polymer,
These include particles containing a magnetic material in a synthetic polymer.

本発明の測定に用いる検体としては、従来の静置法及び
遠心法で用いられる血清、尿、体液等の他全血を使用で
きる。全血を使用した場合には、間接凝集反応後、磁性
体粒子又は磁性体を含む粒子成分だけを強制沈降させる
ため、血球成分は、容器全体に広がり底面の一点には磁
性体粒子又は磁性体を含む粒子を含む成分のみ選択的に
集中する。このため全血を使用しても磁性体粒子又は磁
性体を含む粒子を含む成分のパターン形成に及ぼす影響
は、事実上無視することができる。また、血球成分によ
り容器が全体に赤色に着色し判定しにくい場合には、プ
レートの上をフィルターで覆い判定を容易にすることが
できる。フィルターとしては、赤色系に着色したものを
使用することができ、ガラス、フィルム、セロハン等よ
り選ぶことができる。
As specimens used in the measurement of the present invention, serum, urine, body fluids, etc. used in conventional static methods and centrifugation methods, as well as whole blood can be used. When whole blood is used, after the indirect agglutination reaction, only the magnetic particles or particle components containing the magnetic material are forcibly settled, so the blood cell components spread throughout the container and the magnetic particles or magnetic material are concentrated at one point on the bottom. selectively concentrate only on components containing particles containing . Therefore, even if whole blood is used, the influence of magnetic particles or components containing magnetic particles on pattern formation can be virtually ignored. In addition, if the entire container is colored red due to blood cell components and is difficult to judge, the top of the plate can be covered with a filter to facilitate the judgment. As the filter, one colored in red can be used, and it can be selected from glass, film, cellophane, etc.

また発明の検体及び試薬を受容する容器としてはプラス
チック類、例えばポリスチレン樹脂、ABS樹脂又はガ
ラス製のU字型又はV字型の容器等を使用できる。これ
ら容器の大きさは問わないが、大量の検体を処理し、取
り扱いが容易であり、鮮明な像を得るために、ポリスチ
レン製のV字型マイクロプレートを好適に用いることが
できる。
Further, as the container for receiving the specimen and reagent of the invention, a U-shaped or V-shaped container made of plastics, such as polystyrene resin, ABS resin, or glass, can be used. Although the size of these containers does not matter, V-shaped microplates made of polystyrene can be suitably used in order to process a large amount of specimen, be easy to handle, and obtain clear images.

本発明の凝集免疫測定装置においては、前記の通り、免
疫測定用検体及び免疫測定用試薬を受容するマイクロプ
レート、該試薬の磁性体粒子又は磁性体を含む粒子を含
む成分を磁力により強制沈降させる手段、及び該マイク
ロプレートを傾斜させた状態にする手段とが必須である
が、これを全自動の凝集測定装置として実際に使用する
際には、第1図に示すように、マイクロプレート供給装
置1、検体分注袋W2、試薬分注装置3、検体及び試薬
撹拌装置4、マイクロプレート低部に磁性体粒子又は磁
性体を含む粒子を磁力で沈降させる強制沈降促進装置5
、引続いてこれを傾斜した状態に置く傾斜処理装置6、
沈降粒子成分のマイクロプレートからの傾斜による剥離
状況を読取るパターン読取り装置7及び使用済みマイク
ロプレートを回収するマイクロプレート回収装置8を組
合せて構成することができる。第1図に示す構成例は、
本発明の測定装置の一実施例であって、本発明を限定す
るものではない。
As described above, in the agglutination immunoassay device of the present invention, a microplate that receives an immunoassay sample and an immunoassay reagent, and a component containing magnetic particles or magnetic particles of the reagent are forcibly sedimented by magnetic force. A means for tilting the microplate and a means for tilting the microplate are essential, but when actually using this as a fully automatic agglutination measuring device, as shown in FIG. 1. Sample dispensing bag W2, reagent dispensing device 3, sample and reagent stirring device 4, forced sedimentation promoting device 5 that uses magnetic force to sediment magnetic particles or particles containing magnetic material in the lower part of the microplate.
, a tilting processing device 6 that subsequently places the same in a tilted state;
It can be constructed by combining a pattern reading device 7 that reads the state of separation of settled particle components from a microplate due to inclination, and a microplate collection device 8 that collects used microplates. The configuration example shown in FIG.
This is an example of the measuring device of the present invention, and is not intended to limit the present invention.

本発明について下記に実施例を示して更に詳細に説明す
る。
The present invention will be explained in more detail by showing examples below.

(実施例) !ML−上 抗ヒトα−フェトプロティン(AFP)感
作フェリコロイド含有ゼラチン粒子の調製 フェリコロイドを含むゼラチン粒子(平均粒径約3ミク
ロン、特開昭59−195151号参照)に抗ヒトAF
P抗体(ウサギ、DACO)を用い、Barnard等
の方法(CIin、 Chem、+  27 (6) 
832(1981))に従い、抗ヒトAFP感作フェリ
コロイド含有ゼラチン粒子を調製した。
(Example) ! ML-1 Preparation of gelatin particles containing ferricolloid sensitized with anti-human α-fetoprotein (AFP) Anti-human AF
Using the P antibody (rabbit, DACO), the method of Barnard et al. (CIin, Chem, +27 (6)
832 (1981)), anti-human AFP sensitized ferricolloid-containing gelatin particles were prepared.

夫隻拠−I 血清中のAFPの測定 各濃変のAFPを含む検体血清を血清希釈用液で10倍
に希釈し、これを1字型マイクロプレートにとり、これ
に実施例1で調製した上記の抗ヒトAFP感作フェリコ
ロイド含有ゼラチン粒子の0.09%含有の分散液25
μlを加え、撹拌し、10分間経過後、磁石を用いた沈
降促進台に5分間静置し、その後磁力の影響の無いパタ
ーン読取台でマイクロプレートを約70@傾け、マイク
ロプレートのウェル底部からの沈降粒子の剥離状況から
免疫反応の有無を判定した。ウェル底部より、沈降粒子
の剥離の見られるものを陰性判定、見られないものを陽
性判定とした。
Base-I Measurement of AFP in Serum Sample serum containing AFP of each concentration was diluted 10 times with serum dilution solution, placed in a single-shaped microplate, and the above prepared in Example 1 was added to the sample serum. A dispersion containing 0.09% of anti-human AFP-sensitized ferricolloid-containing gelatin particles 25
Add μl, stir, and after 10 minutes, leave it for 5 minutes on a sedimentation promotion stand using a magnet. Then, tilt the microplate about 70° on a pattern reading stand that is not affected by magnetic force, and The presence or absence of an immune reaction was determined from the detachment of the precipitated particles. A case where sediment particles were observed to be peeled off from the bottom of the well was judged as negative, and a case where no separation was observed was judged as positive.

本発明による上記の免疫測定方法とセロディア・A F
 Pmono (α−フェトプロティン測定用試薬、富
士レビオ株式会社製)を用いた従来の静置法(従来法)
について、それぞれの力価の相関図を第2図に示す。
The above immunoassay method according to the present invention and Celodia AF
Conventional standing method using Pmono (α-fetoprotein measurement reagent, manufactured by Fujirebio Co., Ltd.) (conventional method)
Figure 2 shows a correlation diagram of the respective titers.

スJiJ汁−」−1血清中のAFPの測定AFPを含む
検体血清を血清希釈用液で10倍に希釈しこれを1字型
マイクロプレートの1大目に50μmとり、2穴目から
8穴目まで希釈用液25μlを加え、さらに1大目より
25μlとり2穴目から8穴目まで順次2n希釈した。
Su JiJ Juice - 1 Measurement of AFP in serum Dilute the sample serum containing AFP 10 times with serum dilution solution, add 50 μm of this to the first hole of a single-shaped microplate, and place it in 8 wells from the 2nd hole. Add 25 μl of the dilution solution up to the first hole, and then take 25 μl from the first hole and dilute it 2n sequentially from the second hole to the eighth hole.

これに実施例1で調製した上記の抗ヒ)AFP惑作フェ
リコロイド含有ゼラチン粒子の0.14%含有の分散液
25μ2を加え、3分間撹拌し、磁石を用いた沈降促進
台に3分間静置し、その後磁力の影響の無いパターン読
取台でマイクロプレートを約45°傾け、マイクロプレ
ートのウェル底部からの沈降粒子の剥離状況から免疫反
応の有無を実施例2と同様に判定した。結果を表1に示
す。
To this was added 25μ2 of the dispersion containing 0.14% of gelatin particles containing anti-AFP-induced ferricolloids prepared in Example 1, stirred for 3 minutes, and left to stand for 3 minutes on a sedimentation accelerator using a magnet. After that, the microplate was tilted at about 45° on a pattern reading stand that is not affected by magnetic force, and the presence or absence of an immune reaction was determined in the same manner as in Example 2 from the detachment of precipitated particles from the bottom of the wells of the microplate. The results are shown in Table 1.

スJ1阻−」エ 全血中のAFPの測定AFPを含む検
体血清を血清希釈用液で5倍に希釈した希釈血清に健常
人の全血を等量加え、これをV字型マイクロプレート1
穴目にとり、実施例3と同様な測定を行い結果を得た。
Measurement of AFP in whole blood A sample serum containing AFP was diluted 5 times with a serum dilution solution.An equal amount of whole blood from a healthy individual was added to the diluted serum, and this was placed in a V-shaped microplate.
A hole was taken, and the same measurements as in Example 3 were performed to obtain the results.

この結果を表1に示す。The results are shown in Table 1.

(発明の効果) 本発明の抗原抗体反応の免疫測定方法及び装置において
は、磁性体粒子又は磁性体を含む粒子を担体として用い
、これを磁力を用いて容器底部に強制沈降させ、次に該
容器を傾斜させ、沈降粒子容器からの剥離状況から抗原
抗体反応の有無を判定するものであるから、従来の遠心
法と同じ効果を磁性体粒子と磁力で達成でき、従来の遠
心法では困難である全自動化も容易に達成できる。さら
に従来の静置法よりもはるかに短時間でかつ振動等の影
響を全く受けることなく、又遠心法では全く不可能であ
る全血を用いての測定が可能である。
(Effects of the Invention) In the immunoassay method and device for antigen-antibody reactions of the present invention, magnetic particles or particles containing magnetic particles are used as carriers, which are forcibly settled at the bottom of the container using magnetic force, and then Since the container is tilted and the presence or absence of an antigen-antibody reaction is determined from the separation status of the precipitated particles from the container, the same effect as the conventional centrifugation method can be achieved using magnetic particles and magnetic force, which is difficult with the conventional centrifugation method. Some full automation can also be easily achieved. Furthermore, it is much shorter than the conventional static method and is completely unaffected by vibrations, and it is possible to perform measurements using whole blood, which is completely impossible with the centrifugation method.

更に本発明の凝集免疫測定方法と従来の静置法との間に
は、それぞれの測定結果に実質的に対応する相関関係が
あり、従来の静置法に代えて使用できる。
Furthermore, there is a correlation between the agglutination immunoassay method of the present invention and the conventional static standing method, which substantially corresponds to the respective measurement results, and the method can be used in place of the conventional static standing method.

また、本発明の方法は、従来の免疫測定法の検体である
血清、尿、体液等の他全血を用いての測定も可能であり
、より簡便な方法を提供する。
Furthermore, the method of the present invention allows measurement using whole blood in addition to conventional immunoassay specimens such as serum, urine, and body fluids, thereby providing a simpler method.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、本発明による全自動磁気沈降促進型の間接凝
集免疫測定装置の一構成例を示すブロック図、第2図は
、本発明による免疫測定方法と従来の静置法(従来法)
についての、それぞれの力価の相関図である。 1・・・マイクロプレート供給装置、2・・・検体分注
装置、3・・・試薬分注装置、4・・・検体及び試薬撹
拌装置、5・・・強制沈降促進装置、6・・・傾斜処理
装置、7・・・パターン読取り装置、8・・・マイクロ
プレート回収装置。
FIG. 1 is a block diagram showing a configuration example of a fully automatic magnetic precipitation-enhanced indirect agglutination immunoassay device according to the present invention, and FIG. 2 shows an immunoassay method according to the present invention and a conventional static method (conventional method).
It is a correlation diagram of each potency for. DESCRIPTION OF SYMBOLS 1... Microplate supply device, 2... Sample dispensing device, 3... Reagent dispensing device, 4... Specimen and reagent stirring device, 5... Forced sedimentation promoting device, 6... Tilt processing device, 7... Pattern reading device, 8... Microplate recovery device.

Claims (3)

【特許請求の範囲】[Claims] (1)磁性体粒子又は磁性体を含む粒子を用いる間接凝
集免疫測定法において (イ)該粒子を容器底部に磁力により強制沈降させる段
階 (ロ)該容器を傾斜させる段階 (ハ)該粒子の該容器底部からの剥離状態を判断する段
階 からなる該測定法。
(1) In an indirect agglutination immunoassay using magnetic particles or particles containing a magnetic substance, (a) a step of forcing the particles to settle at the bottom of the container by magnetic force, (b) a step of tilting the container, and (c) a step of causing the particles to settle at the bottom of the container. The measuring method comprises the step of determining the state of peeling from the bottom of the container.
(2)検体として全血液を用いてなる、請求項(1)記
載の方法
(2) The method according to claim (1), which uses whole blood as the specimen.
(3)免疫測定用検体及び免疫測定用試薬を受容する容
器と、該免疫測定用試薬の磁性体粒子又は磁性体を含む
粒子を含む成分を沈降を磁力によって強制沈降させる手
段と、該容器を傾斜させる手段とを有することを特徴と
する間接凝集免疫測定装置。
(3) a container for receiving an immunoassay sample and an immunoassay reagent; a means for forcibly settling magnetic particles or a component containing magnetic particles of the immunoassay reagent; An indirect agglutination immunoassay device comprising: means for tilting.
JP1329556A 1989-10-31 1989-12-21 Indirect agglutination immunoassay method and device Expired - Lifetime JP2683944B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP1329556A JP2683944B2 (en) 1989-12-21 1989-12-21 Indirect agglutination immunoassay method and device
CA002028995A CA2028995A1 (en) 1989-10-31 1990-10-30 Indirect agglutination immunoassay and apparatus therefor
ES90120939T ES2054195T3 (en) 1989-10-31 1990-10-31 IMMUNOLOGICAL TEST OF INDIRECT AGGLUTINATION AND APPARATUS FOR THE SAME.
EP90120939A EP0426170B1 (en) 1989-10-31 1990-10-31 Indirect agglutination immunoassay and apparatus therefor
DE69007587T DE69007587T2 (en) 1989-10-31 1990-10-31 Indirect agglutination immunodetection method and device therefor.
KR1019900017534A KR940009958B1 (en) 1989-10-31 1990-10-31 Indirect agglutination immunoassay and apparatus therefore
AU65720/90A AU626044B2 (en) 1989-10-31 1990-10-31 Indirect agglutination immunoassay and apparatus therefor
US08/082,373 US6258607B1 (en) 1989-10-31 1993-06-28 Indirect agglutination immunoassay and apparatus therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1329556A JP2683944B2 (en) 1989-12-21 1989-12-21 Indirect agglutination immunoassay method and device

Publications (2)

Publication Number Publication Date
JPH03191864A true JPH03191864A (en) 1991-08-21
JP2683944B2 JP2683944B2 (en) 1997-12-03

Family

ID=18222677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1329556A Expired - Lifetime JP2683944B2 (en) 1989-10-31 1989-12-21 Indirect agglutination immunoassay method and device

Country Status (1)

Country Link
JP (1) JP2683944B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05297001A (en) * 1992-04-15 1993-11-12 Fujirebio Inc Automatic immunoassay method and apparatus using magnetic particles
JPH06324041A (en) * 1993-05-17 1994-11-25 Fujirebio Inc Indirect agglutination immunoassay and sedimentation pattern measuring device used therefor
JPH06324042A (en) * 1993-05-17 1994-11-25 Fujirebio Inc Indirect agglutination immunoassay and its apparatus

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011133364A (en) * 2009-12-24 2011-07-07 Beckman Coulter Inc Method and apparatus for determiing hemagglutination image

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02107968A (en) * 1988-10-15 1990-04-19 Olympus Optical Co Ltd Immunoassay using magnetic particle
JPH02124464A (en) * 1988-07-20 1990-05-11 Olympus Optical Co Ltd Immunological measuring method using magnetic marker

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02124464A (en) * 1988-07-20 1990-05-11 Olympus Optical Co Ltd Immunological measuring method using magnetic marker
JPH02107968A (en) * 1988-10-15 1990-04-19 Olympus Optical Co Ltd Immunoassay using magnetic particle

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05297001A (en) * 1992-04-15 1993-11-12 Fujirebio Inc Automatic immunoassay method and apparatus using magnetic particles
JPH06324041A (en) * 1993-05-17 1994-11-25 Fujirebio Inc Indirect agglutination immunoassay and sedimentation pattern measuring device used therefor
JPH06324042A (en) * 1993-05-17 1994-11-25 Fujirebio Inc Indirect agglutination immunoassay and its apparatus

Also Published As

Publication number Publication date
JP2683944B2 (en) 1997-12-03

Similar Documents

Publication Publication Date Title
US5318914A (en) Process and magnetic device for immunological analysis of a solid phase
US5863802A (en) Method and test kit detecting antigens and/or antibodies
JP5223676B2 (en) Magnetic immunodiagnostic method, especially for the demonstration of the presence of blood group antibody / antigen complexes
EP0351857A2 (en) Immunoassay method using magnetic marker particles
JPH01163662A (en) Detection of antigen and/or antibody and test kit for detection
US4297104A (en) Method of detecting or identifying virus antigens, erythrocyte or cell antigens or antibodies in a biological medium
JP4167491B2 (en) Whole blood measurement method
US20110207151A1 (en) Utilisation de ferrofluides pour le phenotypage sanguin et applications derivees
WO1989001161A1 (en) Turbidimetric assay
JPH03191864A (en) Indirect agglutination immunoassay method and device
US6258607B1 (en) Indirect agglutination immunoassay and apparatus therefor
JP2532670B2 (en) Immunological measurement method using magnetic marker particles
EP0426170B1 (en) Indirect agglutination immunoassay and apparatus therefor
JPH08201391A (en) Immunological measuring method with marker grain
WO1989011102A1 (en) Capillary flow device and double capture assay method
JPH03144367A (en) Indirect agglutination immunoassay method and device
WO1986007463A1 (en) Microtiter - surface - flocculation assay for antigen or antibody screening
EP0435245B1 (en) Reaction kit
JP2614997B2 (en) Reaction accelerator for agglutination reaction
JP2716227B2 (en) Immunological measurement method using magnetic marker particles
JP2009030997A (en) Blood group determining kit for type and screening and blood group determining device using the same
JPH02210262A (en) Method for indirectly measuring flocculation reaction
JPH07117541B2 (en) Immunological measurement method using magnetic particles
JP2647931B2 (en) Immunological measurement method
JP5047702B2 (en) Red blood cell type determination method

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080815

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080815

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090815

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090815

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100815

Year of fee payment: 13

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100815

Year of fee payment: 13